Increased CD28 expression has been shown to correlate with improved survival in head and neck squamous cell carcinoma (HNSCC), while increased FLT3LG expression has previously been shown to correlate with improved survival in cervical cancer [28,44]. This evidence concerns the gene CD28 and head and neck squamous cell carcinoma.